Valuation: Retractable Technologies, Inc.

Market Cap 17.4M 15.54M 14.35M 13.01M 24.33M 1.65B 24.73M 173M 68.37M 865M 65.29M 63.9M 2.73B P/E 2024
-1.7x
P/E 2025 -1.8x
Enterprise Value -18.37M -16.41M -15.16M -13.73M -25.7M -1.74B -26.12M -182M -72.2M -914M -68.95M -67.48M -2.88B EV / Sales 2024
-0.69x
EV / Sales 2025 -0.33x
Free-Float
35.63%
Yield 2024 *
-
Yield 2025 -
1 day-0.33%
1 week+0.87%
Current month-15.90%
1 month-16.36%
3 months-14.54%
6 months-10.28%
Current year-24.74%
1 week 0.58
Extreme 0.5762
0.59
1 month 0.58
Extreme 0.576
0.71
Current year 0.58
Extreme 0.576
0.79
1 year 0.58
Extreme 0.576
1.01
3 years 0.56
Extreme 0.5649
1.34
5 years 0.56
Extreme 0.5649
10.19
10 years 0.54
Extreme 0.54
21.5
Manager TitleAgeSince
Chief Executive Officer 75 09/05/1994
Director of Finance/CFO 57 01/04/2019
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 75 09/05/1994
Director/Board Member 78 22/03/2005
Director/Board Member 57 01/04/2019
Date Insider Type Main position Quantity % Market Cap. Importance
14/11/25 Buy

Chief Executive Officer

5,731 0.0191%
11/11/25 Buy

Chief Executive Officer

100 0.0003%
05/11/25 Buy

Chief Executive Officer

7,500 0.0251%
Change 5-day change 1-year change 3-year change Capi.($)
-0.33%+0.87%-38.90%-51.98% 17.4M
+1.16%-1.13%-17.92%+8.27% 179B
+0.02%+4.24%-19.82%+16.53% 118B
-1.22%+0.70%+1.27%+31.80% 117B
+2.29%+17.36%-41.94%+9.49% 93.26B
-2.21%-2.91%+0.74%+75.30% 63.16B
-1.06%+1.75%+13.50%+80.00% 55.68B
-0.75%+3.73%+6.64%-22.28% 54.18B
-1.13%+0.00%-12.25%+31.02% 44.15B
+0.17%+5.85%-4.92%-10.64% 33.95B
Average -0.31%+3.33%-11.36%+16.75% 75.84B
Weighted average by Cap. -0.00%+3.09%-11.69%+22.47%

Financials

2024 2025
Net sales 33.05M 29.51M 27.26M 24.71M 46.23M 3.14B 46.99M 328M 130M 1.64B 124M 121M 5.18B 38.27M 34.17M 31.57M 28.61M 53.52M 3.63B 54.41M 380M 150M 1.9B 144M 141M 6B
Net income -11.89M -10.61M -9.81M -8.89M -16.63M -1.13B -16.9M -118M -46.72M -591M -44.61M -43.66M -1.86B -12.57M -11.22M -10.37M -9.39M -17.57M -1.19B -17.87M -125M -49.39M -625M -47.16M -46.15M -1.97B
Net Debt -43.33M -38.69M -35.75M -32.39M -60.61M -4.11B -61.61M -430M -170M -2.16B -163M -159M -6.79B -35.77M -31.94M -29.51M -26.74M -50.03M -3.4B -50.85M -355M -141M -1.78B -134M -131M -5.61B
Projected Income Statement - Annual - Retractable Technologies, Inc.
Logo Retractable Technologies, Inc.
Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.
Employees
198
Date Price Change Volume
23/10/26 $0.5811 -0.33% 12,096
22/10/26 $0.5830 +0.34% 20,568
21/10/26 $0.5810 -0.02% 33,509
20/10/26 $0.5811 +0.54% 13,707
19/10/26 $0.5780 +0.33% 13,209